RECOVER: Researching COVID to Enhance Recovery
Use of metformin in adults with diabetes linked to lower risk of Long COVID
In this study - 75% of patients with long COVID-19 developed DIABETES within a year of acute infection with COVID-19. That Long COVID-19 is a major risk for metabolic dysfunction is well known by now
New onset diabetes after COVID-19 (NODAC)
"Patients with NODAC have evidence of persistent insulin resistance on follow up, underscoring the need for long term glycemic monitoring."
Thanks to the #LongCovid community!
You inspired us and continue to inspire everyday.
Thank you!